Free Trial

Immunovant (IMVT) SEC Filings & 10K Form

Immunovant logo
$26.63 -1.42 (-5.06%)
(As of 11/15/2024 ET)

Recent Immunovant SEC Filings

DateFilerForm TypeView
11/07/2024
5:42 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:49 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
3:21 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:23 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:25 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:27 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:28 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:30 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:31 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
6:40 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:15 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:12 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:19 PM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
3:17 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:19 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:20 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:36 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:38 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:39 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:41 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:42 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:04 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:06 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:07 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
5:56 AM
Immunovant (Filer)
Form DEF 14A
06/26/2024
6:01 AM
Immunovant (Filer)
Form DEFA14A
05/29/2024
3:36 PM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/26/2024
4:22 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:18 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:20 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:57 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:59 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:01 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:05 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:06 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:18 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:14 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:16 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:54 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:31 PM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:34 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
How one pattern has averaged an 85% return per year since the pandemic. (Ad)

Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern…

Follow this link here and enter your email address to sign up…
04/04/2024
3:37 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:39 PM
Immunovant (Issuer)
Stout Jay S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:44 PM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:46 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:48 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:50 PM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:23 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:27 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:29 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:14 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:16 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:18 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:21 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:47 AM
Deep Track Capital, LP (Filed by)
Immunovant (Subject)
Form SC 13G/A
02/12/2024
6:02 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:05 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/09/2024
8:16 AM
Immunovant (Subject)
Form SC 13G
01/19/2024
3:04 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:29 AM
Geffner Michael (Reporting)
Immunovant (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/12/2024
3:34 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:18 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:20 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
7:08 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:37 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
3:25 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:28 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:30 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:19 PM
Immunovant (Subject)
MIGAUSKY GEORGE V (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:19 PM
Fromkin Andrew J. (Reporting)
Immunovant (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:20 PM
Immunovant (Subject)
Pande Atul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
6:43 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
1:55 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:45 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:47 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:51 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
1:41 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMVT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners